Association of Sipa1-545(C/T) polymorphism with breast cancer risk and tumor characteristics in Chinese women

Chinese Journal of Clinical Oncology

Volumn 36, Issue 20, 2009, Pages 1183-1186

  Liu, Fang ^a,b   Wu, Yan ^b   Xu, Ye ^a   Ouyang, Tao ^a   Li, Jinfeng ^a   Wang, Tianfeng ^a   Fan, Zhaoqing ^a   Fan, Tie ^a   Lin, Benyao ^a   Xie, Yuntao ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

Breast cancer; C erbB2; Polymorphism; Risk; Sipa1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER MORPHOLOGY; CANCER RISK; CANCER STAGING; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUTANT; ONCOGENE C ERB; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIPA1 545 GENE; TUMOR VOLUME; WILD TYPE;

EID: 77951570836     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2009.20.013     Document Type: Article

References (9)

1. Farina A, Hattori M, Qin J, et al. Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization[J]. Mol Cell Biol, 2004, 24(20): 9059-9069. (Pubitemid 39313910)
2. Wada Y, Kubota H, Maeda M, et al. Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human[J]. Genomics, 1997, 39(1): 66-73. (Pubitemid 27057273)
3. Crawford NP, Ziogas A, Peel DJ, et al. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer[J]. Breast Cancer Res, 2006, 8(2): R16. (Pubitemid 44377915)
4. Park YG, Zhao X, Lesueur F, et al. Sipa1 is a candidate for under. lying the metastasis efficiency modifier locus Mtes1[J]. Nat Genet, 2005, 37(10): 1055-1062. (Pubitemid 41486657)
5. Nilsson G, Skytting B, Xie Y, et al. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome[J]. Cancer Res, 1999, 59(13): 3180-3184. (Pubitemid 29316020)
6. Kurachi H, Wada Y, Tsukamoto N, et al. Human SPA1 gene product selectively expressed in lymphoid tissues is a specific GT-Pase-activating protein for Rap1 and Rap2 Segregate expression profiles from a rap1 GAP gene product[J]. J Biol Chem, 1997, 272 (44): 28081-28088. (Pubitemid 27473617)
7. Kometani K, Aoki M, Kawamata S, et al. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model [J]. Cancer Res, 2006, 66(20): 9967-9976. (Pubitemid 44672049)
8. Zhang Z, Mitra RS, Henson BS, et al. Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma[J]. Am J Pathol, 2006, 168(2): 585-596. (Pubitemid 43271156)
9. Zhang J, Liu Y. HER2 over-expression and response to different chemotherapy regimens in breast cancer[J]. J Zhejiang Univ Sci B, 2008, 9(1): 5-9. (Pubitemid 351436991)